Latest filing published 20 Apr 2021 for Kronos Bio, Inc., €440k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +24.7%Entry US$15.40 · Close at T+365 US$19.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jakob Loven: trading record in brief
Jakob Loven is a declared insider at 2 companies; the most frequent names are Kronos Bio, Inc. and Arvinas, Inc. The record holds 21 filings, for trades running from 1 October 2018 to 20 April 2021.
In open-market terms, that means 1 purchase worth €4.3M on one side and 17 sales worth €4.9M on the other. The net balance comes to €570k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2021 to date brings no purchases and 17 sales.
The latest filing, published on 20 April 2021, reports an open-market sale of €166k in Kronos Bio, Inc. The most recent open-market purchase was published on 3 October 2018, 2,959 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jakob Loven
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,292 shares@ US$20.846.1% of flowCommon StockSEC:0001209191-21-027623:0
- 7,870 shares@ US$21.562.0% of flowCommon StockSEC:0001209191-21-027623:1
- 9,847 shares@ US$20.252.3% of flowCommon StockSEC:0001209191-21-027623:2
- 4,157 shares@ US$21.381.0% of flowCommon StockSEC:0001209191-21-027623:3
- 21,532 shares@ US$20.105.0% of flowCommon StockSEC:0001209191-21-027623:4
- 19 shares@ US$20.630.0% of flowCommon StockSEC:0001209191-21-027623:5
- 13,698 shares@ US$22.383.5% of flowCommon StockSEC:0001209191-21-026871:3
- 18,938 shares@ US$23.105.1% of flowCommon StockSEC:0001209191-21-026871:4
- 24,818 shares@ US$21.786.3% of flowCommon StockSEC:0001209191-21-026871:5
- 9,997 shares@ US$23.352.7% of flowCommon StockSEC:0001209191-21-026871:0
- 5,738 shares@ US$24.401.6% of flowCommon StockSEC:0001209191-21-026871:1
- 1,285 shares@ US$25.180.4% of flowCommon StockSEC:0001209191-21-026871:2
- 38,312 shares@ US$27.0912.1% of flowCommon StockSEC:0001209191-21-026394:0
- 24,816 shares@ US$27.918.1% of flowCommon StockSEC:0001209191-21-026394:1
- 21,660 shares@ US$27.206.9% of flowCommon StockSEC:0001209191-21-026394:2
- 15,728 shares@ US$26.274.8% of flowCommon StockSEC:0001209191-21-026394:3
- 100 shares@ US$27.210.0% of flowCommon StockSEC:0001209191-21-026394:4
- 169,031 shares@ US$16.15100.0% of flowCommon StockSEC:0001209191-20-055041:1
- 1,376,313 sharesCommon StockSEC:0001209191-20-055041:0
- 1,381,851 sharesCommon StockSEC:0000899243-18-026069:1
- 312,500 shares@ US$16.00100.0% of flowCommon StockSEC:0000899243-18-026069:0Canonical exit: 30 Dec 2018 (T+90)
21 of 21 declarations
